We lead global healthcare technology. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ people. Transforming the lives of two people every second, every hour, every day. Medtronic. Engineering the extraordinary.

We’re committed to partnerships with interventional radiologists, pathologists, oncologists, surgeons, and the GI community for proactive GI care.

Products and Services


Three interchangeable needles — the FNA, FNB, and FNF — allow for predictable biliary access, fine needle aspiration, fine needle biopsy, fiducial placement and improved procedural workflow in one procedure. 1-8

  • The six distal cutting edges of the SharkCore™ FNB needle are specifically designed to obtain cohesive units of tissue with intact cell architecture.9-11
  • The Beacon™ FNA needle, an interchangeable component of the Beacon™ EUS delivery system, is designed to improve tissue yield.1,12-13
  • The Beacon™  FNF  needle, pre-loaded with two solid gold markers, helps simplify the procedure, and reduces overall procedure time.14

FNB Needle

FNA Exchange System

FNF Needle


The Emprint™ SX ablation platform with Thermosphere™ technology is a cutting-edge, integrated surgical navigation and ablation platform that reduces procedural complexity and improves the targeting accuracy of soft tissue ablation.

  • Navigation software improves successful antenna placement versus standard ultrasound guidance upon first attempt.
  • Advanced 3-D tracking shows the position of the Emprint™ SX ablation antenna and ultrasound transducer relative to the surgeon’s perspective in real-time.
  • Projected antenna path allows trajectory planning prior to antenna placement.
  • 3-D visualization of the predicted ablation zone helps ensure complete coverage of the target.
  • Thermosphere™ technology creates predictable spherical ablation zones.
  • Intuitive interface with a step-by-step guided setup and context-sensitive troubleshooting, makes the system easy to use.

Emprint Ablation Platform

Emprint™ SX Ablation Platform with Thermosphere™ Technology


Call: 1.516.350.3809


  • Hidden
  • This field is for validation purposes and should be left unchanged.

1TR110601 Rev 01 DV Report Dated November 11, 2011 (Data on file)

2PPQ Report: TR-20009 Rev 01 dated March 9, 2015 (Data on File)

3AA study report: TR-20003 Rev 01 dated March 18, 2015 (Data on file)

4510k study TR100509 Rev 01 dated September 21, 2010 (Data on file).

5AA study TR100706 Rev 01 dated January 6, 2011 (Data on file).

6AA study TR110716 Rev 01 dated December 16, 2011 (Data on file).

7DV/PPQ report: TR110601 Rev 01 dated November 11, 2011 (Data on file).

8Based on internal testing data,V-0450-02 (Access DVT Report) dated February 8, 2019 (Data on file).

9Internal test report #1085, July 8, 2014 and Internal test report #1090, September 25, 2014 (Data on file).

10DiMaio CJ, Kolb JM, Benias PC, et al. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): results of a large North American multicenter study. Endosc Int Open. 2016;4(9):E974–E979.

11Jovani M, Abidi WM, Lee LS. Novel fork-tip needles versus standard needles for EUS-guided tissue acquisition from solid masses of the upper GI tract: a matched cohort study. Scand J Gastroenterol. 2017;52(6–7):784–787.

12Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is two betterthan one? A comparison of EUS-FNA efficiency of single-vs multi-needle platforms. Gastrointest Endosc. 2013;77(5S):AB179.

13Moore JZ, Zhang Q, McGill CS, et al. Modeling of the plane needle cutting edge rake and inclination angles for biopsy. J Manuf Sci Eng 2010;132:051005-1-051005-8.22b.

14Kothari S, Kothari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience with a New 22-Gauge “Pre-loaded” EUS Fiducial Needle The American Journal of Gastroenterology, vol 110, Supplement 1 October 2015

15De Cobelli F et al. microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol(2017)34:49

16Takahashi H et al. Local Recurrence After Laparoscopic Radiofrequency Ablation of Malignant Liver Tumors: Results of a Contemporary Series. Surgery. 2017 doi: 10.1016/j.surg.2017.10.026.

17Vogl et al. (2017). Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zone. International Journal of Hyperthermia, DOI: 10.1080/02656736.2017.1358408.

18Imajo K. et al. New microwave ablation system for unresectable liver tumors that forms large, spherical ablation zones. J Gastroenterol Hepatol. 2018;33(12):2007-2014.

19Vogl, TJ., Basten, LM., Nour-Eldin, A., Kaltenbach, B., Bodelle, B., Wichmann, JL., Ackermann, H., Naguib, NNN. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zones. Int J Hyperthermia. 2018 Jun;34(4):492-500.

20Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867-876.